Drugs / NY-ESO-1 Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02737787 | Apr 2016 → Apr 2023 | fallopian tube neoplasm, ovarian cancer, primary peritoneal carcinoma | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NY-ESO-1 Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02737787 ↗ |
| Modality | Vaccine | “NY-ESO-1 OLP4 vaccine” NCT02737787 ↗ |